In hepatocellular carcinoma (HCC) models (Hep3B and HepG2 cells), inhibition of either GNPAT or USP30 significantly reduces DRP1 protein levels, triggering mitochondrial fusion and suppressing cancer cell proliferation and HCC progression. The gene discussed is DNM1L; the disease is cancer.